Lobe Sciences Announces Results of Annual General and Special Meeting of Shareholders
Lobe Sciences Ltd. (CSE:LOBE)(OTCQB:LOBEF)(FSE:LOBE.F) ("Lobe" or the "Company"), a biopharmaceutical company advancing therapeutic development programs through focused subsidiary companies, today announced the voting results from its Annual General and Special Meeting of Shareholders (the "Meeting") held on July 30, 2026.A total of 152,807,032 common shares were represented at the Meeting, representing approximately 49.6% of the Company's...
Read more







